Keywords
Microwave ablation
TACE
Primary liver cancer
Liver function
Survival status
Submitted : 2023-12-24
Accepted : 2024-01-08
Published : 2024-01-23
Abstract
Objective: To explore the effect of transarterial chemoembolization (TACE) + CT-guided microwave ablation (MWA) on treating patients with primary liver cancer. Methods: 78 primary liver cancer cases were enrolled and divided into groups according to their assigned surgical plans. The control group was treated with TACE alone, and the observation group was treated with TACE + CT-guided MWA. The efficacy of the treatment and the liver function indicators and follow-up results of the patients of the two groups were compared. Results: The efficacy of the treatment received by the observation group was higher than that of the control group. Besides, the patients in the observation group exhibited better improvement in liver function indicators after 3 months of treatment. Furthermore, the survival rates of 1 and 2 years after surgery of the observation group were all higher than those of the control group (P < 0.05). Conclusion: TACE combined with CT-guided MWA is more effective in treating primary liver cancer compared to TACE alone. Besides, it resulted in better improvement of liver function and long-term survival rate. Therefore, this treatment regime should be popularized.
References
Tan Z, 2023, The Value of CT-Guided 125I Seed Implantation in the Treatment of Residual Lesions After Transcatheter Arterial Chemoembolization of Primary Liver Cancer. Imaging Research and Medical Applications, 7(1): 185–187.
Yang H, Zhong T, 2022, The Guiding Role of Dynact in Transcatheter Arterial Chemoembolization and its Efficacy Evaluation Value in Patients with Primary Liver Cancer. Journal of Clinical Hepatobiliary Diseases, 38(4): 851–856.
Zhu B, Zhou B, 2023, Clinical Study on Hepatic Arterial Chemoembolization Combined with B-Ultrasound-Guided Microwave Ablation in the Treatment of Patients with Primary Liver Cancer. Chinese Journal of Clinical Pharmacology, 39(8): 1077–1081.
Medical Administration and Medical Administration Bureau of the National Health Commission of the People’s Republic of China, 2020, Standards for Diagnosis and Treatment of Primary Liver Cancer (2019 Edition). Infectious Disease Information, 33(6): 481–500.
Li H, He C, Yang Y, 2021, Clinical Efficacy of CT-Guided Microwave Ablation Combined with Transcatheter Arterial Chemoembolization in the Treatment of Primary Liver Cancer and its Impact on Serum Indicators. Cancer Progress, 19(21): 2224–2228.
Zhang Y, Feng B, Zhang M, et al., 2019, Effects of Arterial Infusion Chemoembolization Interventional Therapy Combined with Radioactive Particles on CT Perfusion Parameters in Patients With Primary Liver Cancer. Journal of Practical Clinical Medicine, 23(17): 55–59.
Li L, He W, Tan L, et al., 2023, Effects of Ultrasound-Guided Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization on Liver Function and Hemodynamics in Patients with Primary Liver Cancer. Cancer Progress, 21(5): 557–560.
Qian Z, Yuan M, Zhu Z, 2023, Analysis of the Efficacy of Hepatic Arterial Chemoembolization Combined with CT-Guided Percutaneous Microwave Ablation in Patients with Primary Liver Cancer in Special Locations. Chinese and Foreign Medical Research, 21(8): 31–34.
Liu L, 2019, Analysis of the Therapeutic Effect of Hepatic Arterial Chemoembolization Combined with CT-Guided Radiofrequency Ablation in Patients with Primary Liver Cancer. Imaging Research and Medical Applications, 3(14): 211–212.
Hou C, 2021, Clinical Efficacy of Hepatic Arterial Chemoembolization and Simultaneous CT-Guided Ablation in the Treatment of Primary Liver Cancer. Chinese Health Care, 39(11): 71–72.